We are a bioanalytical lab that has evolved the model for partnership in large molecule bioanalysis to benefit our customers and the patients they serve.
BioAgilytix is Your Expert Resource for COVID-19 Testing
We’re committed to applying our specialized clinical assay expertise to help customers test for and understand the impacts of SARS-CoV-2 and the associated COVID-19 disease.
With the complete suite of assays you need & fully operational labs, we’re ready to help today. See how.
Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics & Pharmacodynamics (PK/PD)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
In this webinar, BioAgilytix’s Dr. Corinna Fiorotti takes a closer look at:
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
June 2, 2020Clinical Trials and Returning to Work: COVID-19 Testing, The Path Forward
May 22, 2020Answering Your Questions on Developing a Relative Potency Assay for an Anti-Influenza mAb
May 6, 2020Frank Horling, Ph.D. Joins BioAgilytix Leadership Team as General Manager, Europe
April 29, 2020BioAgilytix Welcomes Jim McNally, Ph.D. to Leadership Team as Chief Scientific Officer – North America
March 13, 2020Supporting CAR-T Development
December 6, 2019CRISPR-Cas9 Milestones: The First In Vivo Clinical Trial Is Now Underway
Services
Platforms
